| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |